文献速递男科与性医学

伐地那非通过抑制HMGB1/RAGE/NF-κB通路改善高血压性勃起功能障碍

Vardenafil Ameliorates Hypertension-Induced Erectile Dysfunction by Suppressing the HMGB1/RAGE/NF-κB Pathway.
PubMed 文献 · Urology · 2026-04-21

该研究在自发性高血压大鼠中探讨PDE5抑制剂伐地那非是否通过调控HMGB1/RAGE/NF-κB通路改善勃起功能障碍及海绵体纤维化。体内外实验显示伐地那非可升高cGMP、NO及p-eNOS/eNOS,减少胶原沉积并恢复α-SMA表达,同时下调HMGB1/RAGE/NF-κB通路及纤维化标志物;HMGB1过表达可部分逆转上述效应,证实通路依赖性。

要点

  • 伐地那非改善高血压大鼠勃起功能并减轻海绵体纤维化
  • 机制涉及抑制HMGB1/RAGE/NF-κB通路及上调p-eNOS/eNOS
  • HMGB1过表达可部分逆转伐地那非效应,提示通路依赖

核心结论

  • 伐地那非可能通过抑制HMGB1/RAGE/NF-κB通路减轻海绵体纤维化,从而改善高血压相关勃起功能障碍。

研究设计与样本

  • 研究采用自发性高血压大鼠进行体内实验,给予伐地那非治疗,并通过电刺激评估勃起功能。
  • 体外构建HMGB1过表达的细胞高血压模型,检测增殖、凋亡及cGMP、NO水平。

主要发现

  • 体内实验中伐地那非显著提高颅内压最大/平均动脉压比值及AUC/平均动脉压比值。
  • 伐地那非升高海绵体组织中cGMP、NO及p-eNOS/eNOS水平,减少胶原沉积并恢复α-SMA表达。
  • 伐地那非下调HMGB1、RAGE、p-NF-κB、TGF-β1及胶原水平。
  • 体外实验中伐地那非促进大鼠血管内皮细胞增殖、抑制凋亡,升高cGMP和NO,增强α-SMA表达。
  • HMGB1过表达可部分逆转伐地那非的上述效应。

临床怎么用

  • 对于高血压相关勃起功能障碍患者,伐地那非可能不仅改善勃起功能,还可能通过抑制HMGB1/RAGE/NF-κB通路减轻海绵体纤维化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigated whether the PDE5 inhibitor vardenafil ameliorates erectile dysfunction (ED) and corporal fibrosis in spontaneously hypertensive rats by regulating the HMGB1/RAGE/NF-κB pathway. METHODS: Spontaneously hypertensive rats were treated with vardenafil. Erectile function was evaluated by electrical stimulation, while the levels of cyclic guanosine monophosphate (cGMP) and NO in corpus cavernosum tissues were quantified using assay kits. Fibrosis was assessed via Masson and immunohistochemistry staining. The HMGB1/RAGE/NF-κB pathway and fibrosis markers were analyzed by Western blot. In vitro, a cellular hypertension model with HMGB1 overexpression was constructed. Cell proliferation and apoptosis were detected via EdU staining and flow cytometry. The levels of cGMP and NO in the cell supernatant were measured, the expression of α-SMA was examined by immunofluorescence, and pathway and fibrosis-related proteins were analyzed by Western blot. RESULTS: In vivo, vardenafil significantly increased intracranial pressure maximum/mean arterial pressure and AUC/mean arterial pressure ratios, elevated the levels of cGMP, NO, and p-eNOS/eNOS, reduced collagen deposition and restored α-SMA expression in rat corpus cavernosum tissue. It also downregulated the levels of HMGB1, RAGE, p-NF-κB, TGF-β1, and collagen. In vitro, vardenafil promoted proliferation, inhibited apoptosis, raised cGMP and NO, and enhanced α-SMA expression of rat vascular endothelial cells. Western blot results aligned with in vivo data, showing upregulation of p-eNOS/eNOS and suppression of the HMGB1/RAGE/NF-κB pathway and fibrotic proteins by vardenafil. However, HMGB1 overexpression partially inverted the effects of vardenafil, confirming pathway dependence. CONCLUSION: Vardenafil has the potential to alleviate cavernosal fibrosis by inhibiting the HMGB1/RAGE/NF-κB pathway, thereby improving hypertension-associated ED.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Zhao L, Wang K, Hua Q, et al. Vardenafil Ameliorates Hypertension-Induced Erectile Dysfunction by Suppressing the HMGB1/RAGE/NF-κB Pathway. Urology. 2026. PMID: 42025928. doi:10.1016/j.urology.2026.04.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。